Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

NCI officials were notably absent from the annual meeting of the Association of American Cancer Institutes and the Cancer Center Administrators Forum in Washington, DC, due to the government shutdown that started on Oct. 1.

Science advocates organize march in DC to demand impeachment of RFK Jr.

Scientists, health care professionals, and supporters will take to the streets on Nov. 5, calling for Congress to remove Robert F. Kennedy Jr. from his position as Secretary of Health and Human Services.

Federal official claims that temporary order blocking RIFs doesn’t apply to HHS

A court filing by Thomas Nagy Jr., deputy assistant secretary for Human Resources and chief human capital officer at HHS, claims that his department can proceed with the 982 RIFs it issued two weeks ago, despite a judge’s temporary order freezing the notices issued by two dozen federal agencies since the government shutdown that began on Oct 1.

October 24, 2025

Vol.51 No.39

By Sara Willa Ernst

Clinical Regulatory News Trials & Tribulations

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).

October 17, 2025

Vol.51 No.38

By Edison T. Liu

News Analysis Regulatory News

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Bowing to the growing animal rights movement, FDA and NIH have made policy changes to discourage animal testing, instead favoring alternative research models.

October 17, 2025

Vol.51 No.38

By Claire Marie Porter and Jacquelyn Cobb

Guest Editorial

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

When the idea of looking at cancer center funding and the cancer burden of cancer center catchment areas came to us in the summer of 2024, we lived in a different context.

October 17, 2025

Vol.51 No.38

By Todd Burus, Caree McAfee and Pamela C. Hull

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight

NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

YOU MAY BE INTERESTED IN

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

Science advocates organize march in DC to demand impeachment of RFK Jr.

Federal official claims that temporary order blocking RIFs doesn’t apply to HHS

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Renew today!

Subscriber content

Never miss an issue!

Login

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight

NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

YOU MAY BE INTERESTED IN

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

Science advocates organize march in DC to demand impeachment of RFK Jr.

Federal official claims that temporary order blocking RIFs doesn’t apply to HHS

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issueWhile cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Never miss an issue!

Login

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough